Natural course of cannabis use disorders

Psychological Medicine

Volumn 45, Issue 1, 2015, Pages 63-72

  Farmer, R F ^a   Kosty, D B ^a   Seeley, J R ^a   Duncan, S C ^a   Lynskey, M T ^b   Rohde, P ^a   Klein, D N ^c   Lewinsohn, P M ^a  

^a OREGON RESEARCH INSTITUTE   (United States)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c STONY BROOK UNIVERSITY   (United States)

Author keywords

Cannabis use disorders; gender differences; marijuana; natural course; onset; recovery; recurrence

Indexed keywords

ADOLESCENT; ADULT; FEMALE; HUMAN; INCIDENCE; INTERVIEW; MALE; MARIJUANA ABUSE; ONSET AGE; PREVALENCE; PROPORTIONAL HAZARDS MODEL; RECURRENT DISEASE; SEX RATIO; TREATMENT OUTCOME; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; FEMALE; HUMANS; INCIDENCE; INTERVIEWS AS TOPIC; MALE; MARIJUANA ABUSE; OREGON; PREVALENCE; PROPORTIONAL HAZARDS MODELS; RECURRENCE; SEX DISTRIBUTION; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84926683289     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S003329171400107X     Document Type: Article

References (55)

1. Agrawal A, Lynskey MT (2006). The genetic epidemiology of cannabis use, abuse and dependence. Addiction 101, 801-812.
2. APA (1987). Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, revised. American Psychiatric Association: Washington, DC.
3. APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
4. APA (2013). Diagnostic and Statistical Manual of Mental Disorders, 5th edn. American Psychiatric Association: Washington, DC.
5. Arnett JJ (2007). Emerging adulthood: what is it, and what is it good for? Child Development Perspectives 1, 68-73.
6. Beseler CL, Hasin DS (2010). Cannabis dimensionality: dependence, abuse and consumption. Addictive Behaviors 35, 961-969.
7. Blanco C, Harford TC, Nunes E, Grant B, Hasin D (2007). The latent structure of marijuana and cocaine use disorders: results from the National Longitudinal Alcohol Epidemiologic Survey (NLAES). Drug and Alcohol Dependence 91, 91-96.
8. Boden JM, Fergusson DM, Horwood LJ (2006). Illicit drug use and dependence in a New Zealand birth cohort. Australian and New Zealand Journal of Psychiatry 40, 156-163.
9. Brook JS, Kessler RC, Cohen P (1999). The onset of marijuana use from preadolescence and early adolescence to young adulthood. Development and Psychopathology 11, 901-914.
10. Brook JS, Lee JY, Finch SJ, Koppel J, Brook DW (2011a). Psychosocial factors related to cannabis use disorders. Substance Abuse 32, 242-251.
11. Brook JS, Zhang C, Brook DW (2011b). Antisocial behavior at age 37: developmental trajectories of marijuana use extending from adolescence to adulthood. American Journal on Addictions 20, 509-515.
12. Calabria B, Degenhardt L, Briegleb C, Vos T, Hall W, Lynskey M, Callaghan B, Rana U, McLaren J (2010). Systematic review of prospective studies investigating "remission" from amphetamine, cannabis, cocaine or opioid dependence. Addictive Behaviors 35, 741-749.
13. Chambers WJ, Puig-Antich J, Hirsch M, Paez P, Ambrosini PJ, Tabrizi MA, Davies M (1985). The assessment of affective disorders in children and adolescents by semistructured interview: test-retest reliability of the Schedule for Affective Disorders and Schizophrenia for School-Age Children, Present Episode version. Archives of General Psychiatry 42, 696-702.
14. Chen CY, O'Brien MS, Anthony JC (2005). Who becomes cannabis dependent soon after onset of use? Epidemiological evidence from the United States: 2000-2001. Drug and Alcohol Dependence 79, 11-22.
15. Chen K, Kandel DB (1995). The natural history of drug use from adolescence to the mid-thirties in a general population sample. American Journal of Public Health 85, 41-47.
16. Chung T, Maisto SA (2006). Relapse to alcohol and other drug use in treated adolescents: review and reconsideration of relapse as a change point in clinical course. Clinical Psychology Review 26, 149-161.
17. Clark DB (2004). The natural history of adolescent alcohol use. Addiction 99 (Suppl. 2), 5-22.
18. Coffey C, Carlin JB, Lynskey MT, Li N, Patton GC (2003). Adolescent precursors of cannabis dependence: findings from the Victorian Adolescent Health Cohort Study. British Journal of Psychiatry 182, 330-336.
19. Cohen P, Cohen J, Kasen S, Velez CN, Hartmark C, Johnson J, Rojas M, Brook J, Streuning EL (1993). An epidemiological study of disorders in late childhood and adolescence: age- and gender-specific prevalence. Journal of Child Psychology and Psychiatry 34, 851-867.
20. Copeland J, Swift W (2009). Cannabis use disorder: epidemiology and management. International Review of Psychiatry 21, 96-103.
21. Farmer RF, Kosty DB, Seeley JR, Olino TM, Lewinsohn PM (2013). Aggregation of lifetime Axis I psychiatric disorders through age 30: incidence, predictors, and associated psychosocial outcomes. Journal of Abnormal Psychology 122, 573-586.
22. Farmer RF, Seeley JR, Kosty DB, Lewinsohn PM (2009). Refinements in the hierarchical structure of externalizing psychiatric disorders: patterns of lifetime liability from mid-adolescence through early adulthood. Journal of Abnormal Psychology 118, 699-710.
23. First MB, Spitzer RL, Gibbon M, Williams JBW (1994). Structured Clinical Interview for Axis I DSM-IV Disorders - Non-Patient Edition. Biometrics Research Department: New York.
24. Flory K, Lynam D, Milich R, Leukefeld C, Clayton R (2004). Early adolescent through young adult alcohol and marijuana use trajectories: early predictors, young adult outcomes, and predictive utility. Development and Psychopathology 16, 193-213.
25. Frank E, Prien RF, Jarrett RB, Keller MB, Kupfer DJ, Lavori PW, Rush AJ, Weissman MM (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder: remission, recovery, relapse, and recurrence. Archives of General Psychiatry 48, 851-855.
26. Gillespie NA, Neale MC, Kendler KS (2009). Pathways to cannabis abuse: a multi-stage model from cannabis availability, cannabis initiation and progression to abuse. Addiction 104, 430-438.
27. Griffith-Lendering MF, Wigman JT, Prince van Leeuwen A, Huijbregts SC, Huizink AC, Ormel J, Verhulst FC, van Os J, Swaab H, Vollebergh WAM (2012). Cannabis use and vulnerability for psychosis in early adolescence - a TRAILS study. Addiction 108, 733-740.
28. Hartman CA, Gelhorn H, Crowley TJ, Sakai JT, Stallings M, Young SE, Rhee SH, Corley R, Hewitt JK, Hopfer CJ (2008). An item response theory analysis of DSM-IV cannabis abuse and dependence criteria in adolescents. Journal of the American Academy of Child and Adolescent Psychiatry 47, 165-173.
29. Hicks BM, Blonigen DM, Kramer MD, Krueger RF, Patrick CJ, Iacono WG, McGue M (2007). Gender differences and developmental change in externalizing disorders from late adolescence to early adulthood: a longitudinal twin study. Journal of Abnormal Psychology 116, 433-447.
30. Hicks BM, Krueger RF, Iacono WG, McGue M, Patrick CJ (2004). The family transmission and heritability of externalizing disorders: a twin-family study. Archives of General Psychiatry 61, 922-928.
31. Johnston LD, O'Malley PM, Bachman JG, Schulenberg JE (2013). Monitoring the Future National Survey Results on Drug Use, 1975-2012: Volume I, Secondary School Students. Institute for Social Research, University of Michigan: Ann Arbor.
32. Kandel DB, Chen K (2000). Types of marijuana users by longitudinal course. Journal of Studies in Alcohol 61, 367-378.
33. Keller MB, Lavori PW, Friedman B, Nielsen E, Endicott J, McDonald-Scott PA (1987). The Longitudinal Interval Follow-Up Evaluation: a comprehensive method for assessing outcome in prospective longitudinal studies. Archives of General Psychiatry 44, 540-548.
34. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005). Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Archives of General Psychiatry 62, 593-602.
35. Krueger RF, Markon KE (2006). Reinterpreting comorbidity: a model-based approach to understanding and classifying psychopathology. Annual Review of Clinical Psychology 2, 111-133.
36. Langenbucher JW, Labouvie E, Martin CS, Sanjuan PM, Bavly L, Kirisci L, Chung T (2004). An application of item response theory analysis to alcohol, cannabis, and cocaine criteria in DSM-IV. Journal of Abnormal Psychology 113, 72-80.
37. Lewinsohn PM, Hops H, Roberts RE, Seeley JR, Andrews JA (1993). Adolescent psychopathology: I. Prevalence and incidence of depression and other DSM-III-R disorders in high school students. Journal of Abnormal Psychology 102, 133-144.
38. Lynskey MT, Grant JD, Nelson EC, Bucholz KK, Madden PAF, Statham DJ, Martin NG, Heath AC (2006). Duration of cannabis use - a novel phenotype? Addictive Behaviors 31, 984-994.
39. Moffitt TE, Caspi A, Kokaua J, Milne BJ, Polanczyk G, Poulton R (2010). How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychological Medicine 40, 899-909.
40. Newcomb MD, Galaif ER, Locke TF (2001). Substance use diagnosis within a community sample of adults: distinction, comorbidity, and progression over time. Professional Psychology: Research and Practice 32, 239-247.
41. Orvaschel H, Puig-Antich J, Chambers WJ, Tabrizi MA, Johnson R (1982). Retrospective assessment of prepubertal major depression with the Kiddie-SADS-E. Journal of the American Academy of Child Psychiatry 21, 392-397.
42. Perkonigg A, Goodwin RD, Fiedler A, Behrendt S, Beesdo K, Lieb R, Wittchen H-U (2008). The natural course of cannabis use, abuse, and dependence during the first decades of life. Addiction 103, 439-449.
43. Poulton R, Moffitt TE, Harrington H, Milne BJ, Caspi A (2001). Persistence and perceived consequences of cannabis use and dependence among young adults: implications for policy. New Zealand Medical Journal 114, 544-547.
44. Rohde P, Andrews J (2006). Substance use disorders. In Child and Adolescent Psychopathology: Theoretical and Clinical Implications (ed. C. A. Essau), pp. 184-220. Routledge: New York.
45. Roxburgh A, Hall WD, Degenhardt L, McLaren J, Black E, Copeland J, Mattick RP (2010). The epidemiology of cannabis use and cannabis-related harm in Australia 1993-2007. Addiction 105, 1071-1079.
46. Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF (2006). Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology 31, 1841-1853.
47. Singer JD, Willett JB (1991). Modeling the days of our lives: using survival analysis when designing and analyzing longitudinal studies of duration and the timing of events. Psychological Bulletin 110, 268-290.
48. Sobell LC, Ellingstad TP, Sobell MB (2000). Natural recovery from alcohol and drug problems: methodological review of the research with suggestions for future directions. Addiction 95, 749-764.
49. Substance Abuse and Mental Health Services Administration (2012). Results from the 2011 National Survey on Drug Use and Health: Summary of National Findings (NSDUH Series H-44; HHS Publication No. (SMA) 12-4713). Substance Abuse and Mental Health Services Administration: Rockville, MD.
50. ter Bogt T, Schmid H, Gabhainn SN, Fotiou A, Vollebergh W (2006). Economic and cultural correlates of cannabis use among mid-adolescents in 31 countries. Addiction 101, 241-251.
51. Windle M, Wiesner M (2004). Trajectories of marijuana use from adolescence to young adulthood: predictors and outcomes. Development and Psychopathology 16, 1007-1027.
52. Wittchen HU, Behrendt S, Höfler M, Perkonigg A, Rehm J, Lieb R, Beesdo K (2009). A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: evidence for heterogeneity and different treatment needs. Drug and Alcohol Dependence 102, 151-157.
53. Wittchen HU, Fröhlich C, Behrendt S, Günther A, Lieb R, Perkonigg A, Rehm J, Zimmermann P (2007). Cannabis use and cannabis use disorders and their relationship to mental disorders: a 10-year prospective-longitudinal study in adolescents. Drug and Alcohol Dependence 88, 60-70.
54. Young SE, Stallings MC, Corley RP, Krauter KS, Hewitt JK (2000). Genetic and environmental influences on behavioral disinhibition. American Journal of Medical Genetics: Neuropsychiatric Genetics 96, 684-695.
55. Zucker RA, Donovan JE, Masten AS, Mattson ME, Moss HB (2008). Early developmental processes and the continuity of risk for underage drinking and problem drinking. Pediatrics 121, S252-S272.